AU2001270129A1 - Human phosphodiesterases - Google Patents

Human phosphodiesterases

Info

Publication number
AU2001270129A1
AU2001270129A1 AU2001270129A AU7012901A AU2001270129A1 AU 2001270129 A1 AU2001270129 A1 AU 2001270129A1 AU 2001270129 A AU2001270129 A AU 2001270129A AU 7012901 A AU7012901 A AU 7012901A AU 2001270129 A1 AU2001270129 A1 AU 2001270129A1
Authority
AU
Australia
Prior art keywords
human phosphodiesterases
phosphodiesterases
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270129A
Inventor
Chandra S. Arvizu
Mariah R. Baughn
Narinder K. Chawla
Li Ding
April J. A. Hafalia
Preeti Lal
Yan Lu
Jayalaxmi Ramkumar
Michael Thornton
Catherine M. Tribouley
Monique G. Yao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001270129A1 publication Critical patent/AU2001270129A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001270129A 2000-06-22 2001-06-21 Human phosphodiesterases Abandoned AU2001270129A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US21374100P 2000-06-22 2000-06-22
US60/213,741 2000-06-22
US21823400P 2000-07-14 2000-07-14
US60/218,234 2000-07-14
US24110000P 2000-10-16 2000-10-16
US60/241,100 2000-10-16
PCT/US2001/020140 WO2001098471A2 (en) 2000-06-22 2001-06-21 Human phosphodiesterases

Publications (1)

Publication Number Publication Date
AU2001270129A1 true AU2001270129A1 (en) 2002-01-02

Family

ID=27395905

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270129A Abandoned AU2001270129A1 (en) 2000-06-22 2001-06-21 Human phosphodiesterases

Country Status (6)

Country Link
US (1) US20030143588A1 (en)
EP (1) EP1309700A2 (en)
JP (1) JP2004512019A (en)
AU (1) AU2001270129A1 (en)
CA (1) CA2409781A1 (en)
WO (1) WO2001098471A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344880B2 (en) 1998-04-24 2008-03-18 Genentech, Inc. Nucleic acid encoding PRO9912 polypeptides
US7282570B2 (en) 1999-04-20 2007-10-16 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7365157B2 (en) 1999-12-23 2008-04-29 Genentech, Inc. PRO9912 polypeptides
US7164001B2 (en) 2000-01-20 2007-01-16 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
AU2002211228A1 (en) * 2000-09-14 2002-03-26 Mount Sinai School Of Medicine Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity
US20040029789A1 (en) * 2001-07-05 2004-02-12 Anderson David W. Novel proteins and nucleic acids encoding same
DE10222845A1 (en) * 2002-05-23 2003-12-04 Dresden Arzneimittel Cloning, expression and characterization of the overall sequence of phosphodiesterase 8B
EP1601782A2 (en) * 2002-11-08 2005-12-07 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
EP1608742A1 (en) * 2002-11-13 2005-12-28 Bayer HealthCare AG DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b)
EP1618192A1 (en) * 2003-04-24 2006-01-25 Skanemejerier Ek.För. Human alkaline sphingomyelinase and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE371740T1 (en) * 1998-12-23 2007-09-15 Pfizer PHOSPHODIESTERASES
US6146876A (en) * 1999-06-11 2000-11-14 Millennium Pharmaceuticals, Inc. 22025, a novel human cyclic nucleotide phosphodiesterase
JP2003523748A (en) * 2000-02-21 2003-08-12 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Novel phosphodiesterase type 7b

Also Published As

Publication number Publication date
WO2001098471A3 (en) 2003-02-27
JP2004512019A (en) 2004-04-22
CA2409781A1 (en) 2001-12-27
WO2001098471A8 (en) 2002-02-14
US20030143588A1 (en) 2003-07-31
WO2001098471A2 (en) 2001-12-27
EP1309700A2 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
AU7862200A (en) Flip-wing tissue retainer
AU2001241963A1 (en) Improved medical procedure
AU2001252135A1 (en) Therapeutic agents
AU2002223827A1 (en) Well treatment
AU9517301A (en) Implant
AU2001260327A1 (en) Chair
AU2001263841A1 (en) Implant
AU2001259702A1 (en) Tissue regrafting
AU2001239975A1 (en) Least choice first arbiter
AU2001233208A1 (en) Human sulfatases
AU2001268525A1 (en) Human kinases
AU2002224553A1 (en) Human proteases
AU2001277959A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU2001238488A1 (en) Human kinases
AU2000263864A1 (en) Tissue specific prodrug
AU2001270129A1 (en) Human phosphodiesterases
AU2371201A (en) Endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2001275723A1 (en) Bougie
AU2001273903A1 (en) Therapeutic agents
AU2002227352A1 (en) Human kinases
AU2001255573A1 (en) Human kinases
AU2001247841A1 (en) Medical procedure
AU4432001A (en) Trityl-type compounds and their use